-
Infographic – U.S. Leads Record Q2 Venture Funding
Venture capital financing broke global records in the second quarter of 2021, with investments in the U.S. accounting for nearly half of all dollars invested.
-
Neuro Disease Start-Up Raises $73M in Early Funds
A new enterprise discovering treatments for neurodegenerative diseases is merging with another start-up and raising $73 million its first venture round.
-
Fitness Tracker Data Show Longer Covid-19 Effects
Data collected from wearable activity trackers show extended cardiac effects in people with Covid-19 infections, in some cases for several months.
-
Univ. Lab Testing Wearable Respiratory Monitor
Medical researchers are assessing the feasibility of a wearable device to detect advance indicators of chronic respiratory disease symptoms.
-
Trial Underway Testing Suicide-Prevention Nasal Spray
A clinical trial testing a nasal spray against a placebo to prevent suicide from depression enrolled its first participants considered at high risk of suicide.
-
3-D Printed Scaffold Helps Regrow Soft Tissue
Researchers developed a biodegradable polymer for printed implant scaffolds that in lab rodents maintains its shape to encourage cell and tissue growth.
-
Infographic – Biotech Index Rebounds in Q2
Since mid-May, NBI rose steadily, closing at 5,148 by the end of June, a gain of nine percent for the quarter and eight percent for the year.
-
GSK, Biotech Partner on Neuro Antibodies in $2.2B Deal
GlaxoSmithKline and biotechnology company Alector Inc. agreed to co-develop two synthetic antibodies for treating neurodegenerative disorders.
-
Microbiome Drug Candidate Licensed in $525M Deal
A therapy designed to regenerate healthy gut microbes for treating dangerous intestinal infections is licensed for commercialization to Nestlé Health Science.
-
Covid-19 Nasal Spray Vaccine Discontinued
A biotechnology company is discontinuing further work on a Covid-19 vaccine nasal spray after clinical trial results show it produces little immune response.